The Introduction of Generic Risperidone in Medicare Part D

OBJECTIVES: The introduction of generic second-generation antipsychotics (SGAs), starting with risperidone in July 2008, could reduce antipsychotic spending and cost-related use barriers. This study examines associations between generic risperidone use and spending and adherence after introduction a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Manag Care
Päätekijät: Fung, Vicki, Price, Mary, Busch, Alisa B., Landrum, Mary Beth, Fireman, Bruce, Nierenberg, Andrew A., Newhouse, Joseph P., Hsu, John
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4915110/
https://ncbi.nlm.nih.gov/pubmed/26799124
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia